These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27048383)

  • 1. Simvastatin-induced cognitive dysfunction: two case reports.
    Suraweera C; de Silva V; Hanwella R
    J Med Case Rep; 2016 Apr; 10():83. PubMed ID: 27048383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin-associated memory loss: analysis of 60 case reports and review of the literature.
    Wagstaff LR; Mitton MW; Arvik BM; Doraiswamy PM
    Pharmacotherapy; 2003 Jul; 23(7):871-80. PubMed ID: 12885101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin related memory dysfunction in a Nigerian woman: a case report.
    Okeahialam BN; Isiguzoro I
    Curr Drug Saf; 2012 Feb; 7(1):33-4. PubMed ID: 22663955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin-induced myopathy, the role of interaction with diltiazem and genetic predisposition.
    Hu M; Mak VW; Tomlinson B
    J Clin Pharm Ther; 2011 Jun; 36(3):419-25. PubMed ID: 21545622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of simvastatin-associated pancreatitis and review of statin-associated pancreatitis.
    Johnson JL; Loomis IB
    Pharmacotherapy; 2006 Mar; 26(3):414-22. PubMed ID: 16503723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin-associated memory loss.
    Orsi A; Sherman O; Woldeselassie Z
    Pharmacotherapy; 2001 Jun; 21(6):767-9. PubMed ID: 11401190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study.
    Wu CC; Sy R; Tanphaichitr V; Hin AT; Suyono S; Lee YT
    J Formos Med Assoc; 2002 Jul; 101(7):478-87. PubMed ID: 12353340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin-induced lactic acidosis: a rare adverse reaction?
    Goli AK; Goli SA; Byrd RP; Roy TM
    Clin Pharmacol Ther; 2002 Oct; 72(4):461-4. PubMed ID: 12386648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial.
    van der Vaart T; Plasschaert E; Rietman AB; Renard M; Oostenbrink R; Vogels A; de Wit MC; Descheemaeker MJ; Vergouwe Y; Catsman-Berrevoets CE; Legius E; Elgersma Y; Moll HA
    Lancet Neurol; 2013 Nov; 12(11):1076-83. PubMed ID: 24090588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ezetimibe/simvastatin.
    Montecucco F; Quercioli A; Mach F
    Expert Opin Drug Saf; 2009 Nov; 8(6):715-25. PubMed ID: 19968571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Inquiries. Do statins alter the risk or progression of dementia?
    Lang T; Clifton J; Neher J; Safranek S
    J Fam Pract; 2018 Sep; 67(9):578-579. PubMed ID: 30216400
    [No Abstract]   [Full Text] [Related]  

  • 12. Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia.
    Sebestjen M; Boh M; Keber I
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):999-1003. PubMed ID: 12635468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia.
    Park S; Kang HJ; Rim SJ; Ha JW; Oh BH; Chung N; Cho SY
    Clin Ther; 2005 Jul; 27(7):1074-82. PubMed ID: 16154486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability of statins is not linked to CYP450 polymorphisms, but reduced CYP2D6 metabolism improves cholesteraemic response to simvastatin and fluvastatin.
    Zuccaro P; Mombelli G; Calabresi L; Baldassarre D; Palmi I; Sirtori CR
    Pharmacol Res; 2007 Apr; 55(4):310-7. PubMed ID: 17289397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease.
    Baigent C; Landray M; Leaper C; Altmann P; Armitage J; Baxter A; Cairns HS; Collins R; Foley RN; Frighi V; Kourellias K; Ratcliffe PJ; Rogerson M; Scoble JE; Tomson CR; Warwick G; Wheeler DC
    Am J Kidney Dis; 2005 Mar; 45(3):473-84. PubMed ID: 15754269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins: The Burglar of Memory?
    Downs TN
    Consult Pharm; 2018 Dec; 33(12):706-710. PubMed ID: 30545434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia.
    Dobs AS; Schrott H; Davidson MH; Bays H; Stein EA; Kush D; Wu M; Mitchel Y; Illingworth RD
    Metabolism; 2000 Sep; 49(9):1234-8. PubMed ID: 11016911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits and menaces related to the use of statins in patients after renal transplantation.
    Chmielewski M; Zdrojewski Z; Rutkowski B
    Ann Transplant; 2002; 7(2):6-10. PubMed ID: 12416466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins may increase the risk of liver dysfunction in patients treated with steroids for active graves' orbitopathy.
    Covelli D; Vannucchi G; Campi I; Currò N; D'Ambrosio R; Maggioni M; Gianelli U; Beck-Peccoz P; Salvi M
    J Clin Endocrinol Metab; 2015 May; 100(5):1731-7. PubMed ID: 25751109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of diabetes in patients treated with HMG-CoA reductase inhibitors.
    Cho Y; Choe E; Lee YH; Seo JW; Choi Y; Yun Y; Wang HJ; Ahn CW; Cha BS; Lee HC; Kang ES
    Metabolism; 2015 Apr; 64(4):482-8. PubMed ID: 25312577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.